However, plasma levels of ADAM17, a disintegrin and metalloproteinase 17 involved in the shedding of EPCR from the endothelial membrane [9], did not significantly differ between PAD stage II patients and age-matched healthy persons with no PAD diagnosis in our study. This evidence concerns the gene PROCR and peripheral arterial disease.